BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18076020)

  • 21. Limitations in improving detection of pancreatic adenocarcinoma.
    Mendieta Zerón H; García Flores JR; Romero Prieto ML
    Future Oncol; 2009 Jun; 5(5):657-68. PubMed ID: 19519205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The inherited genetic component of sporadic pancreatic adenocarcinoma.
    Milne RL; Greenhalf W; Murta-Nascimento C; Real FX; Malats N
    Pancreatology; 2009; 9(3):206-14. PubMed ID: 19352090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myeloperoxidase and superoxide dismutase polymorphisms are associated with an increased risk of developing pancreatic adenocarcinoma.
    Wheatley-Price P; Asomaning K; Reid A; Zhai R; Su L; Zhou W; Zhu A; Ryan DP; Christiani DC; Liu G
    Cancer; 2008 Mar; 112(5):1037-42. PubMed ID: 18205184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hereditary pancreatic cancer: a clinical perspective.
    Greer JB; Lynch HT; Brand RE
    Best Pract Res Clin Gastroenterol; 2009; 23(2):159-70. PubMed ID: 19414143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genotype/phenotype of familial pancreatic cancer.
    Brand RE; Lynch HT
    Endocrinol Metab Clin North Am; 2006 Jun; 35(2):405-15, xi. PubMed ID: 16632102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening for pancreatic cancer in high-risk individuals: a call for endoscopic ultrasound.
    Larghi A; Verna EC; Lecca PG; Costamagna G
    Clin Cancer Res; 2009 Mar; 15(6):1907-14. PubMed ID: 19276278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single-nucleotide polymorphisms in DNA double-strand break repair genes: association with head and neck cancer and interaction with tobacco use and alcohol consumption.
    Werbrouck J; De Ruyck K; Duprez F; Van Eijkeren M; Rietzschel E; Bekaert S; Vral A; De Neve W; Thierens H
    Mutat Res; 2008 Oct; 656(1-2):74-81. PubMed ID: 18768166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased expression and promoter methylation of the menin tumor suppressor in pancreatic ductal adenocarcinoma.
    Cavallari I; Silic-Benussi M; Rende F; Martines A; Fogar P; Basso D; Vella MD; Pedrazzoli S; Herman JG; Chieco-Bianchi L; Esposito G; Ciminale V; D'Agostino DM
    Genes Chromosomes Cancer; 2009 May; 48(5):383-96. PubMed ID: 19170121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Demographics and epidemiology of pancreatic cancer.
    Yeo TP; Lowenfels AB
    Cancer J; 2012; 18(6):477-84. PubMed ID: 23187833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Demographics, epidemiology, and inheritance of pancreatic ductal adenocarcinoma.
    Yeo TP
    Semin Oncol; 2015 Feb; 42(1):8-18. PubMed ID: 25726048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between ECT2 gene expression and methylation change of ECT2 promoter region in pancreatic cancer.
    Zhang ML; Lu S; Zhou L; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):533-8. PubMed ID: 18842503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pancreatic cancer: a review of the evidence on causation.
    Hart AR; Kennedy H; Harvey I
    Clin Gastroenterol Hepatol; 2008 Mar; 6(3):275-82. PubMed ID: 18328435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. International registries of families at high risk of pancreatic cancer.
    Greenhalf W; Malats N; Nilsson M; Bartsch D; Neoptolemos J
    Pancreatology; 2008; 8(6):558-65. PubMed ID: 18818508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Familial pancreatic cancer--concept for study of the National Case Collection and early diagnosis program for high risk people].
    Gerdes B; Kress R; Rieder H; Sina-Frey M; Przypadlo E; Barth P; Rehder H; Hahn SA; Schmiegel W; Rothmund M; Ziegler A; Bartsch DK
    Z Arztl Fortbild Qualitatssich; 2002 May; 96(4):251-5. PubMed ID: 12068743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Life style factors and acquired susceptibility to environmental disease.
    Au WW
    Int J Hyg Environ Health; 2001 Oct; 204(1):17-22. PubMed ID: 11725340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetics of hereditary pancreatic carcinoma.
    Hahn SA; Bartsch DK
    Clin Lab Med; 2005 Mar; 25(1):117-33. PubMed ID: 15749235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increasing survival rates of patients with pancreatic cancer by earlier identification.
    Greenhalf W; Neoptolemos JP
    Nat Clin Pract Oncol; 2006 Jul; 3(7):346-7. PubMed ID: 16826198
    [No Abstract]   [Full Text] [Related]  

  • 38. Pancreatic cancer development and progression: remodeling the model.
    Real FX; Cibrián-Uhalte E; Martinelli P
    Gastroenterology; 2008 Sep; 135(3):724-8. PubMed ID: 18692502
    [No Abstract]   [Full Text] [Related]  

  • 39. Molecular pathogenesis of pancreatic ductal adenocarcinoma and clinical implications.
    Magee CJ; Greenhalf W; Howes N; Ghaneh P; Neoptolemos JP
    Surg Oncol; 2001; 10(1-2):1-23. PubMed ID: 11719025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishment and characterization of 4 new human pancreatic cancer cell lines: evidences of different tumor phenotypes.
    Chifenti B; Morelli M; Zavaglia M; Coviello DA; Guerneri S; Santucci A; Paffetti A; Masetti M; Locci MT; Bertacca G; Capodanno A; Collecchi P; Campani D; Mosca F; Bevilacqua G; Cavazzana AO
    Pancreas; 2009 Mar; 38(2):184-96. PubMed ID: 19002021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.